TY - JOUR AU - De Felice, Francesca AU - Benevento, Ilaria AU - Magnante, Anna Lisa AU - Musio, Daniela AU - Bulzonetti, Nadia AU - Caiazzo, Rossella AU - Tombolini, Vincenzo PY - 2017 DA - 2017/05/12 TI - Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis JO - BMC Cancer SP - 325 VL - 17 IS - 1 AB - Neoadjuvant fluoropirimidine (5FU)-based chemoradiotherapy (CRT) has been considered the standard of care for locally advanced rectal cancer (LARC). Whether addition of oxaliplatin (OXP) will further improve clinical outcomes is still debated. We conducted a meta-analysis to evaluate the role of OXP in this patient population. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-017-3323-4 DO - 10.1186/s12885-017-3323-4 ID - De Felice2017 ER -